On Tuesday, Judge Cynthia A. Bashant of the Southern District issued an order denying a preliminary injunction requested by a San Diego group who sued the San Diego Unified School District to challenge its anti-bullying program. The program was originally developed to address a rise in Islamophobia.
“[The order] is a helpful guidepost for others who are trying to take meaningful productive steps to protect students in their schools, whether they’re targeted for race, gender, sexual orientation or something else,” said partner Moez Kaba in an article for the Daily Journal.
Alex Romain was recently featured in the latest issue of Attorney at Law Downtown LAmagazine as Attorney of the Month. The article perfectly captures and discusses how Mr. Romain seamlessly blends his passions for practice of law and music as well as an inside scoop into his family life and background.
On the afternoon of Friday, August 10, Hueston Hennigan LLP secured the dismissal of a putative consumer class action against dietary supplement manufacturer Nutraceutical Corporation in Welk v. Nutraceutical Corporation, No. 3:17-cv-02266-BEN-KSC (S.D. Cal.). U.S. District Court Judge Roger Benitez held that Welk’s claims were preempted by federal law.
Hueston Hennigan lawyers Brian Hennigan, Joshua Michaelangelo Stein and Michael Todisco worked closely with Loyola Law School’s Project for the Innocent to secure the release of Maria Mendez, a grandmother wrongfully convicted of causing the death of her baby grandson.
Today, the Supreme Court of the United States granted Hueston Hennigan’s petition for a writ of certiorari, filed on behalf of client Nutraceutical Corp., in a significant class action matter presenting the question of whether equitable exceptions apply to mandatory claim-processing rules.
Allergan subsidiary Zeltiq Aesthetics defeated a putative class action suit on Tuesday alleging that customers of the company’s popular CoolSculpting fat-freezing system were deceived by marketing materials that classified the system as “FDA-cleared,” without also stating that it was not “FDA-approved.”